Visterra bringing influenza immunotherapy into Phase 2 with $30M cash influx

October 3, 2014 10:46 am

Leave a Reply

Your email address will not be published. Required fields are marked *


Get in touch

Give us a call, or drop us an email. We'd love to hear from you!

Get in touch now